Overview

SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Patients experiencing a mild heart attack will receive one of two medications which thin the blood to discern which is superior.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Treatments:
Enoxaparin